Tunlametinib
- Generic Name
- Tunlametinib
- Indication
适用含抗PD-1/PD-L1治疗失败的NRAS突变的晚期黑色素瘤、结直肠癌患者。
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath